Trial Profile
Randomised Study to Evaluate the Efficacy and Safety of Fentanyl-TTS Versus Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDs (Non-steroidal Anti-inflammatory Drugs).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Sep 2012
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary) ; Dihydrocodeine; Tramadol
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 07 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jan 2008 New trial record.